This cluster carries no actionable signal. The sales are mechanically tied to option exercises/vesting and are negligible relative to Teva's market cap. Monitor next 10-Q for fundamental performance rather than insider flows.
TEVA drugs
TEVA drug pipeline →How the stock moved after the report
NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · Jun 9 $34.45entry
- T+1 · 5mo ago −2.53%α −0.95% · $33.58
- T+5 · 5mo ago −2.21%α −4.62% · $33.69
- T+20 · 4mo ago +0.58%α −0.87% · $34.65
- T+60 · 3mo ago +8.47%α +4.65% · $37.37
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Two senior Teva executives, the CEO and an EVP, sold a combined $744K in open-market stock over a three-day window alongside multiple directors exercising zero-strike derivatives. At $39.8B market cap, the $744K represents 0.0019% of equity, trivially small. The derivative exercises by directors are non-cash events with zero economic signal. The cluster is a routine vesting-and-sell pattern, not a material insider signal.
Key Financial Metrics
Key Facts
- CEO Francis Richard D sold 6,153 shares on June 5, 2026 at $34.35 for ~$211K, a fraction of his total holdings
- EVP Shields Matthew sold 16,195 shares on June 3, 2026 at $32.87 for ~$532K
- Six directors exercised zero-strike derivatives for 14,492 shares each, non-cash, zero economic signal
- Total cluster value of $744K is only 0.0019% of Teva's $39.8B market cap
- Shields' sale directly followed and matched his derivative exercise, consistent with cashless vesting
Financial Impact
$744K total insider sales against $39.8B market cap, immaterial
Risk Factors
- Insider selling at $34.35 near recent highs could precede broader weakness, but dollar amount is too small to read meaningfully
- CEO sale, though small, is the first open-market sale from this insider in the available window worth noting
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-TEVA-1780949085079 |
Track record
61 reports on TEVA
6 of 8 bullish or bearish reports moved the stock their way by T+60. Best: +33.06% at T+60 after the Jul 20, 2026 report. 15 of 17 went positive at some point.
Filters
- Nov 16, 2026today SC 13G/A Neutral 2/10 Entry $43.16 Now $42.57 −1.37% settles Feb 12
- Nov 12, 20264d ago 3 Neutral 2/10 Entry $44.50 Now $42.57 −4.34% settles Feb 11
- Nov 12, 20264d ago 144 Neutral 2/10 Entry $44.50 Now $42.57 −4.34% settles Feb 11
- Nov 12, 20264d ago 144 Neutral 2/10 Entry $43.65 Now $42.57 −2.47% settles Feb 10
- Nov 10, 20266d ago 144 Neutral 3/10 Entry $43.24 Now $42.57 −1.55% settles Feb 9
- Nov 10, 20266d ago SC 13G/A Neutral 3/10 Entry $42.40 Now $42.57 +0.40% settles Feb 8
- Nov 9, 20267d ago 144 Neutral 2/10 Entry $42.40 Now $42.57 +0.40% settles Feb 8
- Nov 6, 202610d ago Insider Cluster Neutral 3/10 Entry $42.97 Now $42.57 −0.93% settles Feb 5
- Nov 6, 202610d ago Insider Cluster Neutral 2/10 Entry $42.97 Now $42.57 −0.93% settles Feb 5
- Nov 5, 202611d ago 144 Neutral 2/10 Entry $42.61 Now $42.57 −0.09% settles Feb 4
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers